In pharmacovigilance databases, anxiety comprised 38.7% of psychiatric adverse event reports, but psychiatric reports as a whole represented only 1.18% of total adverse event reports for GLP-1 receptor agonists
The analysts remained optimistic that this class of drugs will have the ability to overcome supply issues and enjoy sustained uptake. Additionally, they said we are also optimistic that reimbursement will steadily expand for weight loss, achieving over $100 billion in global sales by 2030.
Patients with certain FTO and MC4R variants may experience more pronounced GI side effects during early GLP-1 therapy, while those with favorable GLP1R genotypes often tolerate dose increases more smoothly
These treatments are prescribed by licensed healthcare providers as part of an individualized plan to support patients in managing their overall health and weight
These cases often arent as bad as they seem
The common substances injected include corticosteroids and hyaluronans